Generics - Generics, Mergers & Acquisitions

Filter

Popular Filters

1 to 25 of 173 results

Sun Pharma finally completes Ranbaxy acquisition

25-03-2015

Indian generic drugmaker Sun Pharmaceutical Industries has at last completed the merger of Ranbaxy Laboratories…

Daiichi SankyoGenericsIndiaMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceutical Industries

CCMD to become Malaysia’s largest pharmaceutical manufacturer

19-03-2015

CCM Duopharma Biotech Berhad (CCMD) looks set to become one of Malaysia’s largest pharmaceutical manufacturers…

CCM DuopharmaGenericsMalaysiaMergers & AcquisitionsProduction

Concordia spends $1.2 billion on Covis Pharma assets

10-03-2015

Canadian pharma and medical devices company Concordia Healthcare Corp has entered into a definitive asset…

Concordia HealthcareCovis PharmaGenericsMergers & AcquisitionsPharmaceutical

US FTC calls for divestitures for Impax buy of CorePharma to proceed

US FTC calls for divestitures for Impax buy of CorePharma to proceed

09-03-2015

US Federal Trade Commission imposes divestiture conditions on proposed acquisition by generic drugmaker…

CorePharmaGenericsImpax LaboratoriesMergers & AcquisitionsPerrigoPilocarpineRegulationUrsodiolUSA

Actavis to sell its Pharmatech unit to TPG

13-02-2015

Ireland-headquartered generics major Actavis has reached a definitive agreement with TPG, the global…

ActavisAptalis PharmaGenericsMergers & AcquisitionsPharmatech

Julphar takes step into Bangladesh market with RAK Pharma acquisition

Julphar takes step into Bangladesh market with RAK Pharma acquisition

13-02-2015

Julphar, the largest Emirati pharmaceutical company, has acquired a majority stake in Bangladesh drugmaker…

BangladeshGenericsJulpharMergers & AcquisitionsRAK Pharmaceuticals

Russian government may consider re-purchase from Abbott

09-02-2015

The Russian government may consider the possibility of the re-purchase of the Russian pharmaceutical…

AbbottGenericsMergers & AcquisitionsPoliticsRussiaVeropharm

UPDATE: Pfizer to acquire Hospira for around $17 billion

UPDATE: Pfizer to acquire Hospira for around $17 billion

05-02-2015

US pharma giant Pfizer has entered into a definitive merger agreement to acquire Hospira, news of which…

BiosimilarsGenericsHospiraMergers & AcquisitionsPfizer

Mylan to acquire certain women’s health businesses from Famy Care

Mylan to acquire certain women’s health businesses from Famy Care

02-02-2015

US generics drugmaker Mylan has signed a definitive agreement to acquire certain female health care businesses…

GenericsIndiaMergers & AcquisitionsMylanWomen's Health

FTC puts conditions on Sun Pharma’s proposed acquisition of Ranbaxy

FTC puts conditions on Sun Pharma’s proposed acquisition of Ranbaxy

01-02-2015

Indian drugmakers Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories have agreed to divest Ranbaxy’s…

Antibiotics and Infectious diseasesGenericsIndiaLegalMergers & AcquisitionsMinocyclineRanbaxy LaboratoriesSun Pharmaceutical IndustriesTorrent PharmaceuticalsUSA

European Commission clears Mylan acquisition of Abbott's European generics business

European Commission clears Mylan acquisition of Abbott's European generics business

29-01-2015

The European Commission has cleared the proposed acquisition of Abbott Laboratories’ non-US developed…

Abbott LaboratoriesEuropeGenericsMergers & AcquisitionsMylan

Actavis to acquire UK generics firm Auden Mckenzie

26-01-2015

Ireland-headquartered generic major Actavis said today that it has reached agreement to acquire UK-based…

ActavisAuden MckenzieGenericsMergers & AcquisitionsUK

India’s Competition Commission asks Sun Pharma to amend Ranbaxy takeover deal

India’s Competition Commission asks Sun Pharma to amend Ranbaxy takeover deal

17-11-2014

The Competition Commission has asked Indian generics company Sun Pharmaceutical Industries, which acquired…

GenericsIndiaMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceutical

Advent and Avista acquire UCB’s generics subsidiary Kremers Urban

Advent and Avista acquire UCB’s generics subsidiary Kremers Urban

07-11-2014

Global private equity investors Advent International and Avista Capital Partners have signed an agreement…

BelgiumGenericsKremers Urban PharmaceuticalsMergers & AcquisitionsUCB

Mylan and Abbott amend terms of their $5.3 billion deal

Mylan and Abbott amend terms of their $5.3 billion deal

23-10-2014

US generic drugmaker Mylan and US drugmaker Abbott Laboratories have revised the pricing terms of their…

AbbottAbbott LaboratoriesGenericsMergers & AcquisitionsUSA

Valeant third-qtr profits beat expectations

20-10-2014

Canadian drugmaker Valeant Pharmaceuticals International has posted third-quarter 2014 financial results…

AllerganFinancialGenericsMergers & AcquisitionsValeant Pharmaceuticals International

Impax Labs goes on a $700 million buying spree

Impax Labs goes on a $700 million buying spree

09-10-2014

US generic drugmaker Impax Laboratories saw its shares leap 11.2% to $26.52 in pre-market trading today,…

Amedra PharmaceuticalsCorePharmaGenericsImpax LaboratoriesLineage TherapeuticsMergers & AcquisitionsTaiwanUSA

Strides Arcolab and Shasun Pharma to merge

Strides Arcolab and Shasun Pharma to merge

03-10-2014

The boards of Indian drugmakers Strides Arcolab and Shasun Pharmaceuticals have approved a scheme of…

GenericsIndiaMergers & AcquisitionsShasun PharmaceuticalsStrides Arcolab

FTC approves final order on Akorn divestment in bid for VersaPharm

FTC approves final order on Akorn divestment in bid for VersaPharm

21-09-2014

Following a public comment period, the US Federal Trade Commission has approved a final order settling…

AkornAntibiotics and Infectious diseasesGenericsLegalMergers & AcquisitionsRifampinUSAVersaPharm

Mylan to acquire US rights to Arixtra Injection from Aspen

Mylan to acquire US rights to Arixtra Injection from Aspen

10-09-2014

US generic drugs major Mylan has entered into an agreement to acquire the US commercialization, marketing…

ArixtraAspen PharmacareCardio-vascularGenericsGlaxoSmithKlineMergers & AcquisitionsMylanUSA

Indian Pharma increasing capital and research spending

Indian Pharma increasing capital and research spending

28-08-2014

With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian…

CiplaDr Reddy's LaboratoriesFinancialGenericsGlenmark PharmaceuticalsIndiaLupinMergers & AcquisitionsResearchSun Pharmaceuticals

Indian pharmaceutical sector to see strong growth, says Moody’s

Indian pharmaceutical sector to see strong growth, says Moody’s

25-08-2014

Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double…

FinancialGenericsIndiaMarkets & MarketingMergers & Acquisitions

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

11-08-2014

The deal between Indian generics company Sun Pharmaceutical Industries which acquired fellow Indian drug…

CCIGenericsIndiaMergers & AcquisitionsPharmaceuticalRanbaxy LaboratoriesSun Pharmaceutical Industries

Alvogen acquires Korean Dream Pharma for $187 million

Alvogen acquires Korean Dream Pharma for $187 million

06-08-2014

Privately-owned US generics firm Alvogen says it has acquired Dream Pharma in South Korea for $187 million…

AlvogenApac DistrictAsia-PacificBusiness FinanceDream PharmaGeneric pharmaceuticalGenericsMergers & AcquisitionsNorthern Region, UgandaPharmaceutical sciences

1 to 25 of 173 results

Back to top